Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$497M |
| 3 |
Apple
AAPL
|
+$432M |
| 4 |
L3Harris
LHX
|
+$340M |
| 5 |
Danaher
DHR
|
+$254M |
Top Sells
| 1 |
Mastercard
MA
|
+$427M |
| 2 |
AbbVie
ABBV
|
+$387M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$270M |
| 5 |
Abbott
ABT
|
+$258M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
776
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $24.8M | 0.01% |
714,958
+67,438
| +10% | +$2.33M |
|
777
Philip Morris
PM
$257B
| $24.6M | 0.01% |
323,915
+21,466
| +7% | +$1.63M |
|
778
Snap-on
SNA
$16.9B
| $24.6M | 0.01% |
156,854
+6,821
| +5% | +$1.07M |
|
|
LK
779
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $24.6M | 0.01% |
1,292,118
+148
| +0% | +$2.81K |
|
780
Takeda Pharmaceutical
TAK
$48.3B
| $24.5M | 0.01% |
1,426,481
-54,006
| -4% | -$929K |
|
|
VER
781
DELISTED
VEREIT, Inc.
VER
| $24.4M | 0.01% |
499,533
+321,472
| +181% | +$15.7M |
|
|
MYOV
782
DELISTED
Myovant Sciences Ltd.
MYOV
| $24.1M | 0.01% |
4,627,784
+277,449
| +6% | +$1.44M |
|
783
East-West Bancorp
EWBC
$14.9B
| $24M | 0.01% |
542,499
-9,835
| -2% | -$436K |
|
784
Sanofi
SNY
$115B
| $24M | 0.01% |
517,508
-15,579
| -3% | -$722K |
|
|
AIV
785
Aimco
AIV
$1.07B
| $23.9M | 0.01% |
3,446,622
+329,602
| +11% | +$2.29M |
|
786
Stoke Therapeutics
STOK
$1.24B
| $23.9M | 0.01% |
1,144,575
+744,575
| +186% | +$15.5M |
|
787
Markel Group
MKL
$24.3B
| $23.8M | 0.01% |
20,145
-3,442
| -15% | -$4.07M |
|
788
Kontoor Brands
KTB
$4.29B
| $23.8M | 0.01% |
677,637
+562,870
| +490% | +$19.8M |
|
789
Prestige Consumer Healthcare
PBH
$3.2B
| $23.5M | 0.01% |
678,564
-1,214
| -0.2% | -$42.1K |
|
790
Voya Financial
VOYA
$7.3B
| $23.4M | 0.01% |
429,687
+350,116
| +440% | +$19.1M |
|
|
NP
791
DELISTED
Neenah, Inc. Common Stock
NP
| $23M | 0.01% |
353,859
+29,661
| +9% | +$1.93M |
|
792
iShares Russell 2000 ETF
IWM
$66.4B
| $23M | 0.01% |
+151,660
| New | +$23M |
|
793
Janus Henderson Short Duration Income ETF
VNLA
$2.76B
| $22.9M | 0.01% |
458,115
+248,716
| +119% | +$12.4M |
|
|
TRHC
794
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $22.9M | 0.01% |
416,785
+74,824
| +22% | +$4.11M |
|
|
TBI
795
Trueblue
TBI
$171M
| $22.9M | 0.01% |
1,084,227
-2,041
| -0.2% | -$43.1K |
|
796
LeMaitre Vascular
LMAT
$2.1B
| $22.9M | 0.01% |
668,694
+2,799
| +0.4% | +$95.7K |
|
797
HF Sinclair
DINO
$9.57B
| $22.7M | 0.01% |
422,614
-717,520
| -63% | -$38.5M |
|
798
Incyte
INCY
$16.8B
| $22.5M | 0.01% |
302,578
+51,665
| +21% | +$3.84M |
|
799
Snap
SNAP
$11.9B
| $22.4M | 0.01% |
1,418,818
+1,363,613
| +2,470% | +$21.5M |
|
800
Loews
L
$19.9B
| $22.2M | 0.01% |
431,610
+286,391
| +197% | +$14.7M |
|